Top Crypto To Buy In December: Dogizen, Sui, Ripple Lead the Way

The feverish mood in the crypto community is impossible to ignore, and tokens like Dogizen, Sui, and Ripple are at the center of the storm. With dog-themed projects leading the way, SUI smashing ATHs, and XRP poised for regulatory-driven growth, the market is primed for explosive gains.

Here’s what you need to know about this December’s top cryptos to buy.

Dogizen (DOGIZ): The first-ever Telegram ICO has the edge

Built on TON, Dogizen is rewriting the rules as the first-ever ICO on Telegram, reaching 950 million users.

Unlike the airdrop approach favored by competitors, Dogizen’s ICO strategy has already raised $1.4m, ensuring a committed user base invested in the project’s success rather than a quick token dump.

This decision builds a more stable price trajectory and carves a niche in the untapped Telegram ecosystem. Unlike rivals like Catizen and Hamster Kombat, which suffered post-airdrop price crashes.

Dog-themed tokens at around a $92 billion market cap continue to dominate investor interest. From DOGE to SHIB, these coins have a proven track record and attract retail investors like moths to a flame.

TON’s ecosystem was recently predicted to outperform Bitcoin over the next two years—which should open the floodgates to a massive wave of new users and investors.

Partnerships with Grindery, Grand Journey, and others enhance Dogizen’s credibility too, while its low market cap sets the stage for potentially 50x if it achieves similar market caps to its peers.

Put it all together, and you have a project perfectly positioned at the crossroads of viral appeal, booming markets, and untapped potential.

Sui (SUI): Breaking records and setting new highs

Sui is turning heads with an incredible 850% growth from its all-time low, making it one of the fastest-rising stars in crypto. Outpacing Solana over the past few months, SUI has delivered a 700% surge from August to November, including a 90% jump in November alone.

This meteoric rise is fueled by growing user trust, as evidenced by new transaction records and increased wallet activity.

The Sui blockchain continues to attract game developers, with Mysten Labs integrating its first permissionless oracle aggregator, Switchboard On-Demand. This innovation delivers high-speed scaling solutions for developers while enhancing user experiences in gaming and DeFi.

Sui’s price momentum reached an ATH of $3.92 in mid-November, and many expect SUI to go higher this December.

Ripple (XRP): Leading the rally with regulatory optimism

Ripple’s XRP token is spearheading the current crypto rally amid signs of favorable regulatory changes. The upcoming departure of SEC Chairman Gary Gensler and Ripple’s prior legal triumph have bolstered optimism, with many expecting the US regulatory landscape to shift in favor of crypto.

Additionally, Donald Trump’s return to the White House raises hopes for pro-crypto policies, positioning the US as a potential blockchain hub.

Speculation around XRP-based ETFs further fuels bullish sentiment as institutional investors eye potential market entry. Ripple CEO Brad Garlinghouse envisions the US embracing blockchain innovation under Trump, solidifying XRP’s role in global markets by 2025.

Don’t miss this December’s top cryptos to buy: DOGIZ, SUI and XRP

While SUI and Ripple offer compelling narratives with their rapid growth and regulatory momentum, Dogizen steals the spotlight as the sleeper hit of this lineup.

Its market cap on launch of just $10 million makes achieving exponential gains easier than with the blue-chip giants. An enormous 100x return for Dogizen requires significantly less capital inflow than it would for SUI or XRP, giving early investors a rare chance to ride an underdog to incredible heights.

For those looking for the top crypto to buy this December, Dogizen’s potential far outweighs its modest presale price of only $0.000077.

The Dogizen presale is underway. Visit the official Dogizen website for further info.

This is a sponsored article. Opinions expressed are solely those of the sponsor and readers should conduct their own due diligence before taking any action based on information presented in this article.